Innovative Approaches to Cancer Acquired Resistance: Precision Immuno- Oncology and Synthetic Immune Lethality
Time: 12:30 pm
day: Conference Day Two
Details:
- Exploring how a combination of synthetic lethality with immunotherapy could form a new class of treatments to tackle acquired resistance in cancers.
- Reviewing how these approaches hold significant potential in improving response rates and survival in cancer patients
